Mercury Laboratories appoints Jaydeepsinh Raj as Manager-HR

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Jaydeepsinh Raj appointed as Manager-HR at Mercury Laboratories
  • Appointment effective September 3, 2026, for full-time employment
  • Raj holds a Bachelor's Degree in Social Work and is aged about 35
  • He brings over 8 years of HR experience from IDMC Limited and Sudeep Pharma
powered bylight_fuzz_icon
50001581

*this image is generated using AI for illustrative purposes only.

Mercury Laboratories has appointed Jaydeepsinh Raj as Manager-HR, effective September 3, 2026. The appointment was disclosed to the BSE under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Raj, aged about 35 years, holds a Bachelor's Degree in Social Work. He brings over 8 years of professional experience in Human Resource Management to the role.

Professional Background

His expertise covers employee relations, talent management, recruitment, HR operations, and performance management. Prior to joining Mercury Laboratories, he was associated with IDMC Limited and Sudeep Pharma Private Limited.

The appointment is for full-time employment. Rajendra Shah, Managing Director of Mercury Laboratories, signed the disclosure on September 3, 2026.

Historical Stock Returns for Mercury Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.29%-3.72%-5.65%-4.94%-10.56%+6.22%

How might Jaydeepsinh Raj's experience in the pharmaceutical sector with IDMC and Sudeep Pharma influence Mercury Laboratories' talent retention strategies?

What specific HR initiatives or organizational changes are expected under the new Manager-HR's leadership in the coming fiscal year?

Does this appointment signal a broader restructuring of Mercury Laboratories' management team or a strategic shift in corporate governance?

Mercury Laboratories schedules 45th AGM on September 28, 2026

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Mercury Laboratories schedules its 45th AGM for September 28, 2026, via VC/OAVM
  • The meeting will consider the approval of a ₹3.5 per share final dividend for FY26
  • Record date for dividend entitlement is fixed as September 21, 2026
  • Remote e-voting facility is available for all shareholders to cast votes on resolutions
  • Dividend payments will be made electronically only, mandating updated bank details
powered bylight_fuzz_icon
48776017

*this image is generated using AI for illustrative purposes only.

Mercury Laboratories has scheduled its 45th Annual General Meeting (AGM) for Monday, September 28, 2026. The meeting will be held through Video Conference (VC) or Other Audio-Visual Means (OAVM) in compliance with Ministry of Corporate Affairs and SEBI circulars.

The primary agenda item is the approval of the final dividend of ₹3.5 per equity share for FY26, as recommended by the Board of Directors in its May 29, 2026 meeting. The company has fixed Monday, September 21, 2026, as the record date to determine eligibility for the dividend payout.

Meeting Logistics and E-Voting

Shareholders can attend and participate in the AGM via the VC/OAVM facility. Instructions for joining the meeting will be provided in the official Notice of the AGM. Members attending through VC/OAVM will be counted for quorum purposes under Section 103 of the Companies Act, 2013.

The company is providing a remote e-voting facility to all members to cast votes on resolutions set out in the Notice. Detailed procedures for remote e-voting and e-voting during the AGM are available in the Notice of the AGM. Electronic copies of the Notice and the Integrated Annual Report for FY25-26 have been sent to shareholders with registered email addresses. Those without registered emails will receive a letter with a web link and QR code.

Dividend Payment and Compliance

If approved at the AGM, the dividend will be paid to eligible shareholders on or after September 28, 2026. In line with regulatory mandates requiring electronic dividend payments, physical modes such as cheques or demand drafts are no longer permitted.

Shareholders must ensure their bank account details, including IFSC codes and KYC information, are updated with their Depository Participants (for demat holdings) or the Registrar and Share Transfer Agent (for physical holdings). Failure to update details may delay payment.

Tax Deduction at Source (TDS) Implications

Under the Income Tax Act, 2025, Mercury Laboratories will deduct tax at source on dividend payouts. Shareholders seeking benefits under Double Taxation Avoidance Agreements (DTAA) or claiming lower/nil TDS must submit relevant documents (Form 121, Form 41, Tax Residency Certificate) by the record date.

Shareholder Category: Applicable TDS Rate: Key Requirements
Resident Individuals 10% Exempt if aggregate dividend ≤ ₹10,000; Form 121 required for nil deduction
Resident Entities (MFs/AIFs) Nil Documentary evidence of exemption status under Schedule VII
Non-Residents (FII/FPI) 20% + surcharge/cess DTAA benefits available via Form 41 and Tax Residency Certificate

Resident individual shareholders can avoid TDS if their total dividend income from the company does not exceed ₹10,000 in the tax year 2026-2027. Non-resident shareholders must submit self-attested PAN, TRC, and e-filed Form 41 by the record date to avail DTAA benefits.

Historical Stock Returns for Mercury Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.29%-3.72%-5.65%-4.94%-10.56%+6.22%

How might the approved ₹3.5 dividend per share impact Mercury Laboratories' future capital allocation strategy and reinvestment capacity for FY27?

What are the potential market reactions to the mandatory shift to electronic-only dividend payments for shareholders with outdated KYC or bank details?

Could the strict TDS compliance requirements, particularly for non-resident investors, influence foreign institutional investment flows into Mercury Laboratories?

More News on Mercury Laboratories

1 Year Returns:-10.56%